Your browser doesn't support javascript.
loading
ß2-microglobulin has a different regulatory molecular mechanism between ER+ and ER- breast cancer with HER2.
Chai, Dandan; Li, Kesheng; Du, Huifen; Yang, Suisheng; Yang, Rong; Xu, Yang; Lian, Xiaowen.
Afiliação
  • Chai D; Department of Medicine Biotechnology, Medicine and Science Research Institute of Gansu Province, Lanzhou, China.
  • Li K; Department of Medicine Biotechnology, Medicine and Science Research Institute of Gansu Province, Lanzhou, China. likesheng63@hotmail.com.
  • Du H; Department of Medicine Biotechnology, Medicine and Science Research Institute of Gansu Province, Lanzhou, China.
  • Yang S; Department of Breast Surgery, Tumor Hospital of Gansu Province, Lanzhou, China.
  • Yang R; Department of Pathology, Tumor Hospital of Gansu Province, Lanzhou, China.
  • Xu Y; Department of Medicine Biotechnology, Medicine and Science Research Institute of Gansu Province, Lanzhou, China.
  • Lian X; Department of Medicine Biotechnology, Medicine and Science Research Institute of Gansu Province, Lanzhou, China.
BMC Cancer ; 19(1): 223, 2019 Mar 12.
Article em En | MEDLINE | ID: mdl-30866857
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Microglobulina beta-2 / Receptor ErbB-2 Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Microglobulina beta-2 / Receptor ErbB-2 Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article